PDF icon PDF herunterladen
Open Access
CC BY 4.0 · Arq Neuropsiquiatr 2025; 83(07): s00451809884
DOI: 10.1055/s-0045-1809884
Brazilian Academy of Neurology

Brazilian Academy of Neurology recommendations for diagnosis, management, and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Osvaldo J. M. Nascimento 
1   Universidade Federal Fluminense, Faculdade de Medicina, Niterói RJ, Brazil.
,
Wilson Marques Jr 
2   Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto SP, Brazil.
,
Marcus Vinícius Magno Gonçalves 
3   Universidade de Joinville, Joinville SC, Brazil.
,
Pedro José Tomaselli 
2   Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto SP, Brazil.
,
Camila Pupe 
1   Universidade Federal Fluminense, Faculdade de Medicina, Niterói RJ, Brazil.
,
Marcondes Cavalcante França Jr 
4   Universidade de Campinas, Faculdade de Ciências Médicas, Campinas SP, Brazil.
,
Francisco de Assis Aquino Gondim 
5   Universidade Federal do Ceará, Faculdade de Medicina, Fortaleza CE, Brazil.
,
Marcos Raimundo Gomes de Freitas 
1   Universidade Federal Fluminense, Faculdade de Medicina, Niterói RJ, Brazil.
,
Rodrigo Siqueira Soares Frezatti 
2   Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto SP, Brazil.
,
Acary Souza Bulle Oliveira 
6   Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo SP, Brazil.
,
Francisco Tellechea Rotta 
7   Hospital Moinhos de Vento, Porto Alegre RS, Brazil.
8   Santa Casa de Misericórdia de Porto Alegre, Porto Alegre RS, Brazil.
,
Elza Dias Tosta 
9   Hospital dos Servidores da União de Brasília, Brasília DF, Brazil.
,
Rosana Scola 
10   Universidade Federal do Paraná, Curitiba PR, Brazil.
,
Vanessa Daccach 
2   Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto SP, Brazil.
,
Carlo Domenico Marrone 
11   Clinica Marrone, Porto Alegre, RS, Brazil.
,
Jefferson Becker 
12   Pontifícia Universidade Católica do Rio Grande do Sul, Escola de Medicina, Instituto do Cérebro, Porto Alegre RS, Brazil.
,
Susanie Rigatto 
13   Hospital Geral de Goiânia, Goiânia GO, Brazil.
,
Alberto R. M. Martinez 
4   Universidade de Campinas, Faculdade de Ciências Médicas, Campinas SP, Brazil.
,
Hideraldo Cabeça 
14   Hospital Geral de Belém, Belém PA, Brazil.
,
Pablo Brea Winckler 
15   Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Porto Alegre RS, Brazil.
,
Mario Emilio Dourado 
16   Universidade Federal do Rio Grande do Norte, Faculdade de Medicina, Natal RN, Brazil.
,
Diogo Fernandes dos Santos 
17   Universidade Federal de Uberlândia, Faculdade de Medicina, Uberlândia MG, Brazil.
› Institutsangaben
› Weitere Informationen
Auch verfügbar aufeRef
  Lizenzen und Reprints
Preview

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired autoimmune disorder that leads to progressive motor and sensory impairment, resulting in significant morbidity. While the incidence rates vary, CIDP remains a challenging condition requiring a standardized and optimized approach to diagnosis and management. In Brazil, a middle-income country with substantial regional disparities in healthcare access, the availability of specialized neuromuscular centers is uneven, creating obstacles to timely and effective treatment. To address these challenges, the Brazilian Academy of Neurology (Academia Brasileira de Neurologia, ABN, in Portuguese) has developed national recommendations for the diagnosis, management, and treatment of CIDP, tailored to the country's healthcare resources. This consensus outlines standardized diagnostic criteria that incorporate electrophysiological and imaging findings, and it emphasizes key differential diagnoses to enhance diagnostic accuracy. The recommendations were developed through expert panel discussions and a non-systematic review of the literature. The recommended treatment strategies include first-line therapies such as corticosteroids, intravenous immunoglobulin (IVIg), and plasmapheresis, with guidance on escalation and titration of immunosuppressive therapy in refractory cases. By emphasizing early intervention to prevent axonal degeneration and disability, these guidelines aim to improve clinical outcomes and support public health policies within the Brazilian National Health System (Sistema Único de Saúde, SUS, in Portuguese), ensuring equitable and effective CIDP management across the country.

Keywords

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - Consensus - Diagnosis - Therapeutics

Authors' Contributions

Conceptualization: OJMN, WMJ, MVMG, PT, CP, FAAQ, RSSF, FTR, EDT, VSM; Data curation: OJMN; Investigation: OJMN, WMJ, MVMG, PT, CP, MCFJ, MRGF, RSSF, ASBO, VSM, CDM; Methodology: OJMN, WMJ, MVMG, PT, MCFJ, FAAQ, MRGF, RSSF, ASBO, FTR, EDT, RHS, CDM, JB, DS; Project administration: OJMN; Resources: OJMN, WMJ, MVG, PT, CP, MCFJ, FAAQ, RSSF, ASBO, FTR, EDT, RHS, VSM, MED; Supervision: OJMN, MED, DS; Validation: RSSF; Visualization: PT, FTR, RHS; Writing – original draft: OJMN, WMJ, MVMG, FAAQ, MRGF, RSSF, EDT, VSM, CDM, JB, SR, ARMM, HC, PBW, MED, DS; Writing – review & editing: OJMN, WMJ, MVG, PT, CP, MCFJ, FAAQ, MRGF, RSSF, ASBO, FTR, EDT, RHS, VSM, CDM, JB, SR, ARMM, HC, PBW, MED, DS.


Data Availability Statement

The contents underlying the research text are included in the manuscript.


Editor-in-Chief: Hélio A. G. Teive 0000-0003-2305-1073.


Associate Editor: Edmar Zanotelli 0000-0002-4991-6760.




Publikationsverlauf

Eingereicht: 28. Februar 2025

Angenommen: 26. April 2025

Artikel online veröffentlicht:
28. Juli 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Osvaldo J. M. Nascimento, Wilson Marques Jr, Marcus Vinícius Magno Gonçalves, Pedro José Tomaselli, Camila Pupe, Marcondes Cavalcante França Jr, Francisco de Assis Aquino Gondim, Marcos Raimundo Gomes de Freitas, Rodrigo Siqueira Soares Frezatti, Acary Souza Bulle Oliveira, Francisco Tellechea Rotta, Elza Dias Tosta, Rosana Scola, Vanessa Daccach, Carlo Domenico Marrone, Jefferson Becker, Susanie Rigatto, Alberto R. M. Martinez, Hideraldo Cabeça, Pablo Brea Winckler, Mario Emilio Dourado, Diogo Fernandes dos Santos. Brazilian Academy of Neurology recommendations for diagnosis, management, and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Arq Neuropsiquiatr 2025; 83: s00451809884.
DOI: 10.1055/s-0045-1809884
 

  • References

  • 1 Nobile-Orazio E. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst 2014; 19 (01) 2-13
    CrossrefPubMedSuche in Google Scholar
  • 2 Van den Bergh PYK, Van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA. et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol 2021; 28 (11) 3556-3583
    CrossrefPubMedSuche in Google Scholar
  • 3 Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975; 50 (11) 621-637
    PubMedSuche in Google Scholar
  • 4 Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989; 46 (08) 878-884
    CrossrefPubMedSuche in Google Scholar
  • 5 Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41 (05) 617-618
    CrossrefPubMedSuche in Google Scholar
  • 6 Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. [Erratum in J Peripher Nerv Syst. 2010 Dec;15(4):373] J Peripher Nerv Syst 2010; 15 (01) 1-9
    CrossrefPubMedSuche in Google Scholar
  • 7 Nicolas G, Maisonobe T, Le Forestier N, Léger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002; 25 (01) 26-30
    CrossrefPubMedSuche in Google Scholar
  • 8 Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000; 57 (12) 1745-1750
    CrossrefPubMedSuche in Google Scholar
  • 9 Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurology 2015; 85 (06) 498-504
    CrossrefPubMedSuche in Google Scholar
  • 10 Broers MC, Bunschoten C, Drenthen J, Beck TAO, Brusse E, Lingsma HF. et al. Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2021; 28 (06) 2065-2073
    CrossrefPubMedSuche in Google Scholar
  • 11 Basta I, Delic N, Gunjic I, Zdraljevic MA, Kacar A, Bozovic I, Peric S. Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia. J Peripher Nerv Syst 2023; 28 (02) 226-236
    CrossrefPubMedSuche in Google Scholar
  • 12 Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis. Neuroepidemiology 2019; 52 (3-4): 161-172
    CrossrefPubMedSuche in Google Scholar
  • 13 Broers MC, De Wilde M, Lingsma HF, Van der Lei J, Verhamme KMC, Jacobs BC. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands. J Peripher Nerv Syst 2022; 27 (03) 182-188
    CrossrefPubMedSuche in Google Scholar
  • 14 Iijima M, Koike H, Hattori N, Tamakoshi A, Katsuno M, Tanaka F. et al; Refractory Peripheral Neuropathy Study Group of Japan. Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry 2008; 79 (09) 1040-1043
    CrossrefPubMedSuche in Google Scholar
  • 15 Laughlin RS, Dyck PJ, Melton III LJ, Leibson C, Ransom J, Dyck PJ. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 2009; 73 (01) 39-45
    CrossrefPubMedSuche in Google Scholar
  • 16 Nascimento OJM. Chronic inflammatory demyelinating polyradiculoneuropathy (Austin-Dyck syndrome): study of 45 cases. Arq Neuropsiquiatr 1995; 53 (3A): 530-531
    CrossrefSuche in Google Scholar
  • 17 Calia LC, Oliveira AS, Gabbai AA. [Chronic inflammatory demyelinating polyradiculoneuropathy. Study of 18 cases]. Arq Neuropsiquiatr 1997; 55 (04) 712-721
    CrossrefSuche in Google Scholar
  • 18 Pasnoor M, Nascimento OJ, Trivedi J, Wolfe GI, Nations S, Herbelin L. et al. North America and South America (NA-SA) neuropathy project. Int J Neurosci 2013; 123 (08) 563-567
    CrossrefPubMedSuche in Google Scholar
  • 19 Santos PL, Almeida-Ribeiro GA, Silva DM, Marques Junior W, Barreira AA. Chronic inflammatory demyelinating polyneuropathy: quality of life, sociodemographic profile and physical complaints. Arq Neuropsiquiatr 2014; 72 (03) 179-183 Doi: 20130232
    CrossrefSuche in Google Scholar
  • 20 Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain 2020; 143 (11) 3214-3224
    CrossrefPubMedSuche in Google Scholar
  • 21 Daccach V, Tomaselli PJ, Algemiro JS, Toscano P, Santos ACJD, Frade MAC, Marques Jr W. Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis. J Peripher Nerv Syst 2024; 29 (03) 356-362
    CrossrefPubMedSuche in Google Scholar
  • 22 Lourenço CM, Dupré N, Rivière JB, Rouleau GA, Marques VD, Genari AB. et al. Expanding the differential diagnosis of inherited neuropathies with non-uniform conduction: Andermann syndrome. J Peripher Nerv Syst 2012; 17 (01) 123-127
    CrossrefPubMedSuche in Google Scholar
  • 23 Marques Jr W, Funayama CA, Secchin JB, Lourenço CM, Gouvêa SP, Marques VD. et al. Coexistence of two chronic neuropathies in a young child: Charcot-Marie-Tooth disease type 1A and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2010; 42 (04) 598-600
    CrossrefPubMedSuche in Google Scholar
  • 24 Allen JA. The Misdiagnosis of CIDP: A Review. Neurol Ther 2020; 9 (01) 43-54
    CrossrefPubMedSuche in Google Scholar
  • 25 Allen JA, Bril V. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy. Neurodegener Dis Manag 2016; 6 (03) 237-247
    CrossrefPubMedSuche in Google Scholar
  • 26 Kobessho H, Oishi K, Hamaguchi H, Kanda F. Elevation of cerebrospinal fluid protein in patients with diabetes mellitus is associated with duration of diabetes. Eur Neurol 2008; 60 (03) 132-136
    CrossrefPubMedSuche in Google Scholar
  • 27 Merkies IS, Schmitz PI. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2006; 77 (08) 970-972
    CrossrefPubMedSuche in Google Scholar
  • 28 Rajabally YA, Nicolas G, Piéret F, Bouche P, Van den Bergh PY. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009; 80 (12) 1364-1368
    CrossrefPubMedSuche in Google Scholar
  • 29 Uncini A. Autoimmune nodo-paranodopathies 10 years later: Clinical features, pathophysiology and treatment. J Peripher Nerv Syst 2023; 28 (Suppl. 03) S23-S35
    CrossrefPubMedSuche in Google Scholar
  • 30 Uncini A, Susuki K, Yuki N. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 2013; 124 (10) 1928-1934
    CrossrefPubMedSuche in Google Scholar
  • 31 Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry 2015; 86 (11) 1186-1195
    CrossrefPubMedSuche in Google Scholar
  • 32 Rajabally YA, Afzal S, Loo LK, Goedee HS. Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2022; 93 (12) 1247-1252
    CrossrefPubMedSuche in Google Scholar
  • 33 Senderek J, Lassuthova P, Kabzińska D, Abreu L, Baets J, Beetz C. et al. The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME . Neurology 2020; 95 (24) e3163-e3179
    CrossrefPubMedSuche in Google Scholar
  • 34 Marques Jr W, Freitas MR, Nascimento OJ, Oliveira AB, Calia L, Melo A. et al. 17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population. J Neurol 2005; 252 (08) 972-979
    CrossrefPubMedSuche in Google Scholar
  • 35 England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA. et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 185-192
    CrossrefPubMedSuche in Google Scholar
  • 36 Cottenie E, Menezes MP, Rossor AM, Morrow JM, Yousry TA, Dick DJ. et al. Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 2013; 23 (05) 399-403
    CrossrefPubMedSuche in Google Scholar
  • 37 Yger M, Stojkovic T, Tardieu S, Maisonobe T, Brice A, Echaniz-Laguna A. et al. Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C. J Peripher Nerv Syst 2012; 17 (01) 112-122
    CrossrefPubMedSuche in Google Scholar
  • 38 Gouvea SP, Tomaselli PJ, Barretto LS, Perina KCB, Nyshyama FS, Nicolau Jr N. et al. New novel mutations in Brazilian families with X-linked Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2019; 24 (02) 207-212
    CrossrefPubMedSuche in Google Scholar
  • 39 Frezatti RSS, Tomaselli PJ, Figueiredo FB, Zuchner S, Reilly MM, Marques Jr W. Conduction block and temporal dispersion in a SIGMAR1-related neuropathy. J Peripher Nerv Syst 2022; 27 (04) 316-319
    CrossrefPubMedSuche in Google Scholar
  • 40 Nascimento OJ, Marques Jr W, Tomaselli P, Lavigne-Moreira C. Neurological Manifestations in ATTRv Amyloidosis. In: Ávila DXd, Villacorta Junior H. editors Amyloidosis and Fabry Disease: A Clinical Guide. Vham, Switzerland: Springer; 2023. . p. 5-17
    Suche in Google Scholar
  • 41 Cortese A, Vegezzi E, Lozza A, Alfonsi E, Montini A, Moglia A. et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry 2017; 88 (05) 457-458
    CrossrefPubMedSuche in Google Scholar
  • 42 Barretto LS. Pesquisa de variantes no gene da transtirretina em pacientes com diagnóstico de polirradiculoneuropatia inflamatória desmielinizante crônica [dissertação]. Ribeirão Preto: Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto; 2021. Doi: 10.11606/D.17.2022.tde-06052022-162429
  • 43 Silva AEd. Avaliação genotípica de pacientes com polineuropatia inflamatória desmielinizante crônica: estudo da duplicação/deleção do gene PMP22 [dissertação]. Ribeirão Preto: Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto; 2014. Doi: 10.11606/D.17.2014.tde-25112014-142430
  • 44 Moodley K, Bill PL, Patel VB. A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients. Neurol Neuroimmunol Neuroinflamm 2016; 4 (02) e315
    CrossrefPubMedSuche in Google Scholar
  • 45 Rajabally YA. The “chronic immune polyradiculopathies”: Diverse but maybe just CIDP after all. Muscle Nerve 2021; 63 (01) 7-9
    CrossrefPubMedSuche in Google Scholar
  • 46 Quinot V, Rostasy K, Höftberger R. Antibody-Mediated Nodo- and Paranodopathies. J Clin Med 2024; 13 (19) 5721
    CrossrefPubMedSuche in Google Scholar
  • 47 Gonçalves TAP, Donadel CD, Frezatti RSS, Garibaldi PMM, Calado RT, Marques Junior W, Tomaselli PJ. Monoclonal gammopathy-associated peripheral neuropathies: Uncovering pearls and challenges. J Peripher Nerv Syst 2024; 29 (02) 161-172 . Doi: 172 10.1111/jns.12638
    CrossrefPubMedSuche in Google Scholar
  • 48 Gerischer LM, Scheibe F, Nümann A, Köhnlein M, Stölzel U, Meisel A. Acute porphyrias - A neurological perspective. Brain Behav 2021; 11 (11) e2389
    CrossrefPubMedSuche in Google Scholar
  • 49 Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY. et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia [published correction appears in Nat Genet. 2019 May;51(5):920. doi: 10.1038/s41588-019-0422-y.]. Nat Genet 2019; 51 (04) 649-658
    CrossrefPubMedSuche in Google Scholar
  • 50 Harding AS, Ghanem KG. The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: a systematic review. Sex Transm Dis 2012; 39 (04) 291-297
    CrossrefPubMedSuche in Google Scholar
  • 51 Amato AA, Ropper AH. Sensory Ganglionopathy. N Engl J Med 2020; 383 (17) 1657-1662
    CrossrefPubMedSuche in Google Scholar
  • 52 Gomatos EL, Dulebohn SC, Rehman A. Sensory Neuropathy. [Updated 2024 Feb 25]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025. . Available from: https://www.ncbi.nlm.nih.gov/books/NBK559020/
    Suche in Google Scholar
  • 53 Ohashi N, Kodaira M, Morita H, Sekijima Y. Electrophysiological demyelinating features in hereditary ATTR amyloidosis. Amyloid 2019; 26 (01) 15-23
    CrossrefPubMedSuche in Google Scholar
  • 54 Uncini A, Cavallaro T, Fabrizi GM, Manganelli F, Vallat JM. Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology. J Peripher Nerv Syst 2024; 29 (02) 135-160
    CrossrefPubMedSuche in Google Scholar
  • 55 Nascimento OJM, Pupe CCB, Cavalcanti EBU. Diabetic neuropathy. Rev Dor 2016; 17 (Suppl. 01) S46-S51
    CrossrefSuche in Google Scholar
  • 56 Pinto MV, Ng PS, Howe BM, Laughlin RS, Thapa P, Dyck PJ, Dyck PJB. Lumbosacral Radiculoplexus Neuropathy: Neurologic Outcomes and Survival in a Population-Based Study. Neurology 2021; 96 (16) e2098-e2108
    CrossrefPubMedSuche in Google Scholar
  • 57 Lefebvre G, Le Corroller T. Ultrasound and MR imaging of peripheral nerve tumors: the state of the art. Skeletal Radiol 2023; 52 (03) 405-419
    CrossrefPubMedSuche in Google Scholar
  • 58 Al Hinai R, Kelly L, O'Connor M, Berman H, Jalil LA, Sowa A. et al. Unraveling the mysteries of parsonage turner syndrome: A journey towards optimal management. A systematic review. J Hand Microsurg 2024; 16 (05) 100142
    CrossrefPubMedSuche in Google Scholar
  • 59 Nascimento OJ. Leprosy neuropathy: clinical presentations. Arq Neuropsiquiatr 2013; 71 (9B): 661-666
    CrossrefPubMedSuche in Google Scholar
  • 60 Tomaselli PJ, Santos DFd, Santos ACJd, Antunes DE, Marques VD, Foss NT. et al. Primary neural leprosy: clinical, neurophysiological and pathological presentation and progression. Brain 2022; 145 (04) 1499-1506
    CrossrefPubMedSuche in Google Scholar
  • 61 Bril V, Blanchette CM, Noone JM, Runken MC, Gelinas D, Russell JW. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. J Diabetes Complications 2016; 30 (07) 1401-1407
    CrossrefPubMedSuche in Google Scholar
  • 62 Rajabally YA, Peric S, Cobeljic M, Afzal S, Bozovic I, Palibrk A, Basta I. Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal. J Neurol Neurosurg Psychiatry 2020; 91 (10) 1100-1104
    CrossrefPubMedSuche in Google Scholar
  • 63 Kitano Y, Kuwabara S, Misawa S, Ogawara K, Kanai K, Kikkawa Y. et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 2004; 56 (04) 462-467
    CrossrefPubMedSuche in Google Scholar
  • 64 De Pémille CV, Noël N, Adam C, Labeyrie C, Not A, Beaudonnet G. et al. Red Flags for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Sarcoidosis or Connective Tissue Diseases. J Clin Med 2023; 12 (09) 3281
    CrossrefPubMedSuche in Google Scholar
  • 65 Bida JP, Kyle RA, Therneau TM, Melton III LJ, Plevak MF, Larson DR. et al. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 2009; 84 (08) 685-693
    CrossrefPubMedSuche in Google Scholar
  • 66 Rodolfi S, Della-Torre E, Bongiovanni L, Mehta P, Fajgenbaum DC, Selmi C. Lymphadenopathy in the rheumatology practice: a pragmatic approach. Rheumatology (Oxford) 2024; 63 (06) 1484-1493
    CrossrefPubMedSuche in Google Scholar
  • 67 El Sadaney AO, Dutta A, Cook J, Baffour FI. Monoclonal Gammopathy of Clinical Significance (MGCS) and Related Disorders: A Review and the Role of Imaging. Diagnostics (Basel) 2024; 14 (17) 29
    CrossrefPubMedSuche in Google Scholar
  • 68 Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev 2017; 1 (01) CD010369
    CrossrefPubMedSuche in Google Scholar
  • 69 Oaklander AL, Gimigliano F. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary. NeuroRehabilitation 2019; 44 (04) 609-612
    CrossrefPubMedSuche in Google Scholar
  • 70 Castle D, Robertson NP. Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 2019; 266 (09) 2338-2340
    CrossrefPubMedSuche in Google Scholar
  • 71 Dyck PJB, Tracy JA. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Mayo Clin Proc 2018; 93 (06) 777-793
    CrossrefPubMedSuche in Google Scholar
  • 72 van Lieverloo GGA, Peric S, Doneddu PE, Gallia F, Nikolic A, Wieske L. et al. Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. J Neurol 2018; 265 (09) 2052-2059
    CrossrefPubMedSuche in Google Scholar
  • 73 Van Schaik IN, Eftimov F, Van Doorn PA, Brusse E, Van den Berg LH, Van der Pol WL. et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9 (03) 245-253
    CrossrefPubMedSuche in Google Scholar
  • 74 Eftimov F, Vermeulen M, Van Doorn PA, Brusse E, Van Schaik IN. PREDICT. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology 2012; 78 (14) 1079-1084
    CrossrefPubMedSuche in Google Scholar
  • 75 Hartung HP. Advances in the understanding of the mechanism of action of IVIg. J Neurol 2008; 255 (Suppl. 03) 3-6
    CrossrefPubMedSuche in Google Scholar
  • 76 Fisse AL, Schäfer E, Hieke A, Schröder M, Klimas R, Brünger J. et al. Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2024; 31 (04) e16205
    CrossrefPubMedSuche in Google Scholar
  • 77 Kuwabara S, Mori M, Misawa S, Suzuki M, Nishiyama K, Mutoh T. et al; Glovenin-I CIDP Study Group. Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry 2017; 88 (10) 832-838
    CrossrefPubMedSuche in Google Scholar
  • 78 Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, Van Doorn PA. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2015; 86 (12) 1331-1336
    CrossrefPubMedSuche in Google Scholar
  • 79 Adrichem ME, Lucke IM, Vrancken AFJE, Goedee HS, Wieske L, Dijkgraaf MGW. et al. Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Brain 2022; 145 (05) 1641-1652
    CrossrefPubMedSuche in Google Scholar
  • 80 Cocito D, Merola A, Peci E, Mazzeo A, Fazio R, Francia A. et al; SCIg and Chronic Dysimmune Neuropathies Italian Network. Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. J Neurol 2014; 261 (11) 2159-2164
    CrossrefPubMedSuche in Google Scholar
  • 81 Beydoun SR, Sharma KR, Bassam BA, Pulley MT, Shije JZ, Kafal A. Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg. Front Neurol 2021; 12: 638816
    CrossrefPubMedSuche in Google Scholar
  • 82 Overton PM, Shalet N, Somers F, Allen JA. Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review. Patient Prefer Adherence 2021; 15: 811-834
    CrossrefPubMedSuche in Google Scholar
  • 83 Abbas A, Rajabally YA. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review. Curr Drug Saf 2019; 14 (01) 3-13
    CrossrefPubMedSuche in Google Scholar
  • 84 Rajabally YA. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks. ImmunoTargets Ther 2024; 13: 99-110
    CrossrefPubMedSuche in Google Scholar
  • 85 Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT. et al; ADHERE Study Group. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 2024; 23 (10) 1013-1024
    CrossrefPubMedSuche in Google Scholar
  • 86 Mair D, Madi H, Eftimov F, Lunn MP, Keddie S. Novel therapies in CIDP. J Neurol Neurosurg Psychiatry 2024; 96 (01) 38-46
    CrossrefPubMedSuche in Google Scholar
  • 87 Allen JA, Eftimov F, Querol L. Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice. Expert Rev Neurother 2021; 21 (07) 805-816
    CrossrefPubMedSuche in Google Scholar
  • 88 Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K. et al; ICE Study Group. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. [Erratum in Lancet Neurol. 2008 Sep;7(9):771] Lancet Neurol 2008; 7 (02) 136-144
    CrossrefPubMedSuche in Google Scholar
  • 89 Allen JA, Gelinas DF, Lewis RA, Nowak RJ, Wolfe GI. Optimizing the use of outcome measures in chronic inflammatory demyelinating polyneuropathy. US Neurol 2017; 13 (01) 26-34
    CrossrefSuche in Google Scholar
  • 90 Kaplan A, Brannagan III TH. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2017; 55 (04) 476-482
    CrossrefPubMedSuche in Google Scholar
  • 91 Cocito D, Paolasso I, Antonini G, Benedetti L, Briani C, Comi C. et al; Italian Network for CIDP Register. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2010; 17 (02) 289-294
    CrossrefPubMedSuche in Google Scholar
  • 92 Spina E, Topa A, Iodice R, Tozza S, Ruggiero L, Dubbioso R. et al. Early predictive factors of disability in CIDP. J Neurol 2017; 264 (09) 1939-1944
    CrossrefPubMedSuche in Google Scholar
  • 93 Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, Van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol 2019; 18 (08) 784-794
    CrossrefPubMedSuche in Google Scholar
  • 94 Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K. et al; ICE Study Group. Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study. Neurology 2009; 72 (15) 1337-1344
    CrossrefPubMedSuche in Google Scholar
  • 95 Berger M, Allen JA. Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach. Muscle Nerve 2015; 51 (03) 315-326
    CrossrefPubMedSuche in Google Scholar
  • 96 Kuwabara S, Isose S, Mori M, Mitsuma S, Sawai S, Beppu M. et al. Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2015; 86 (10) 1054-1059
    CrossrefPubMedSuche in Google Scholar
  • 97 Ryan M, Ryan SJ. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health. Am J Manag Care 2018; 24 (17, Suppl): S371-S379
    PubMedSuche in Google Scholar
  • 98 Kim W, Shim YK, Choi SA, Kim SY, Kim H, Lim BC. et al. Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases. Neuromuscul Disord 2019; 29 (09) 684-692
    CrossrefPubMedSuche in Google Scholar
  • 99 Mahdi-Rogers M, Brassington R, Gunn AA, Van Doorn PA, Hughes RA. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2017; 5 (05) CD003280
    CrossrefPubMedSuche in Google Scholar
  • 100 Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A. et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 2014; 82 (10) 879-886
    CrossrefPubMedSuche in Google Scholar
  • 101 Huijbers MG, Querol LA, Niks EH, Plomp JJ, Van der Maarel SM, Graus F. et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 2015; 22 (08) 1151-1161
    CrossrefPubMedSuche in Google Scholar
  • 102 Querol L, Illa I. Paranodal and other autoantibodies in chronic inflammatory neuropathies. Curr Opin Neurol 2015; 28 (05) 474-479
    CrossrefPubMedSuche in Google Scholar
  • 103 Hung SKY, Hiew FL, Viswanathan S, Puvanarajah S. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression. J Peripher Nerv Syst 2018; 23 (03) 183-189
    CrossrefPubMedSuche in Google Scholar